Palvella Therapeutics (PVLA)
NASDAQ:PVLA
Palvella Therapeutics (PVLA) Ownership Overview
2.01% Insiders
8.42% Mutual Funds
43.73% Other Institutional Investors
8.35% ETFs
37.49% Public Companies and
Individual Investors
The ownership structure of Palvella Therapeutics (PVLA) stock is a mix of institutional, retail, and individual investors. Approximately 60.50% of the company’s stock is owned by Institutional Investors, 2.01% is owned by Insiders, and 37.49% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Apr 01, 2026 | xxxxxxxxxxxxx | $49974 | |
Mar 02, 2026 | xxxxxxxxxxxxx | $500000 | |
Mar 02, 2026 | xxxxxxxxxxxxx | $300000 | |
Apr 10, 2025 | xxxxxxxxxxxxx | $100797 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $3141146 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $27872260 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $31457103 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 483,496 | Institution | 3.54% | 60,944,671 | |
| 418,618 | Institution | 3.06% | 52,766,799 | |
| 399,722 | Institution | 2.92% | 50,384,958 | |
| 300,536 | Institution | 2.20% | 37,882,563 | |
| 284,773 | Institution | 2.08% | 35,895,637 | |
| 274,584 | Institution | 2.01% | 34,611,313 | |
| 266,287 | Institution | 1.95% | 33,565,476 | |
| 231,120 | Institution | 1.69% | 29,132,676 | |
| 200,687 | Insider | 1.47% | 25,296,596 | |
| 161,258 | Institution | 1.18% | 20,326,571 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 418,618 | Institution | 3.06% | 52,766,799 | |
| 399,722 | Institution | 2.92% | 50,384,958 | |
| 231,120 | Institution | 1.69% | 29,132,676 | |
| 161,258 | Institution | 1.18% | 20,326,571 | |
| 130,685 | Institution | 0.96% | 16,472,844 | |
| 101,748 | Institution | 0.74% | 12,825,335 | |
| 94,597 | Institution | 0.69% | 11,923,952 | |
| 74,771 | Institution | 0.55% | 9,424,885 | |
| 70,572 | Institution | 0.52% | 8,895,601 | |
| 45,900 | Institution | 0.34% | 5,785,695 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 316,154 | Institution | 2.31% | 24,245,850 | |
| 252,078 | Institution | 1.84% | 30,768,641 | |
| 173,254 | Institution | 1.27% | 21,147,383 | |
| 83,461 | Institution | 0.61% | 6,400,624 | |
| 56,223 | Institution | 0.41% | 6,862,579 | |
| 35,837 | Institution | 0.26% | 4,838,712 | |
| 21,715 | Institution | 0.16% | 1,665,323 | |
| 19,114 | Institution | 0.14% | 2,333,055 | |
| 17,194 | Institution | 0.13% | 2,098,700 | |
| 15,785 | Institution | 0.12% | 2,156,231 |
FAQ
Who Owns Palvella Therapeutics (PVLA)?
According to the latest TipRanks data, approximately 43.73% of the company's stock is held by institutional investors, 2.01% is held by insiders, and 37.49% is held by retail investors.
What percentage of Palvella Therapeutics (PVLA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 43.73% of Palvella Therapeutics (PVLA) stock is held by institutional investors.
What percentage of Palvella Therapeutics (PVLA) stock is held by retail investors?
According to the latest TipRanks data, approximately 37.49% of Palvella Therapeutics (PVLA) stock is held by retail investors.
Who owns the most shares of Palvella Therapeutics (PVLA)?
Vanguard owns the most shares of Palvella Therapeutics (PVLA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.